NEOPROL is the developer of a new formulation for anesthesia drugs. The companys NP-09 is an advanced preclinical development of an improved formulation and novel bioequivalent of propofol, with proven superiority over Diprivan.
NEOPROLs formulation is based on an invention by Professor Nissim Garti.